Error: Could not add to watchlist. X

AXA Framlington Biotech Fund

+ Watchlist
FRABIOA:LN
179.70
GBp
0.70
0.39%
As of 00:59:30 ET on 07/06/2015.
Volume
0
Previous Close
179.00
52Wk Range
105.27 - 186.60
1 Yr Return
54.80%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/06/2015)
179.7
Total Assets (m GBp) (on 07/06/2015)
759.298
Inception Date
11/26/2001
Last Dividend (on 03/02/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
1.95%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 987.09 k 72.31 m 9.60
Biogen Inc 240.48 k 62.52 m 8.30
Celgene Corp 773.91 k 58.00 m 7.70
Amgen Inc 522.62 k 53.48 m 7.10
Illumina Inc 273.49 k 36.91 m 4.90
Alexion Pharmaceuticals Inc 329.96 k 35.40 m 4.70
Vertex Pharmaceuticals Inc 394.49 k 33.14 m 4.40
Regeneron Pharmaceuticals Inc 94.25 k 31.63 m 4.20
Incyte Corp 365.48 k 26.36 m 3.50
BioMarin Pharmaceutical Inc 320.60 k 26.36 m 3.50
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
ADDRESS
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
PHONE
44-207-374-4100